pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
(celecoxib + valacyclovir hydrochloride)
Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)
$DWTXDogwood Therapeutics, Inc.
0 catalysts
Phase 2
(cilnidipine + tadalafil)
(cilnidipine [INN] + tadalafil)
Systemic Sclerosis (Scleroderma)
AISA Pharma Inc
0 catalysts
Phase 2
(colistimethate sodium + zidovudine)
Zidistin ((colistimethate sodium + zidovudine))
Urinary Tract Infections
Helperby Therapeutics Group Ltd
0 catalysts
← prev
page 2 of 50
next →
131
Pain89
Neurology1
Phase 2
(difluprednate + povidone iodine)
(difluprednate + povidone iodine [USP])
Viral Conjunctivitis
iView Therapeutics Inc
0 catalysts
Phase 2
(docetaxel + gemcitabine) SR
(docetaxel + gemcitabine)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$RLMDRELMADA THERAPEUTICS, INC.
0 catalysts
Phase 2
(dronabinol + melatonin)
(dronabinol + melatonin [INN])
Dementia Associated With Alzheimer's Disease
$IGCIGC Pharma, Inc.
0 catalysts
Phase 2
(ensifentrine + glycopyrrolate)
Chronic Obstructive Pulmonary Disease (COPD)
Verona Pharma Ltd
0 catalysts
Phase 2
(ganaplacide + lumefantrine)
(ganaplacide [INN] + lumefantrine)
Malaria
$NVSNOVARTIS AG
0 catalysts
Phase 2
(halobetasol + lidocaine hydrochloride)
Hemorrhoids
$CTXRCitius Pharmaceuticals, Inc.
0 catalysts
Phase 2
(heparin sodium + lidocaine hydrochloride)
(heparin sodium [INN] + lidocaine hydrochloride)
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)
Vaneltix Pharma Inc
0 catalysts
Phase 2
(mazorelvimab + zamerovimab)
(mazorelvimab [INN] + zamerovimab [INN])
Rabies
Synermore Biologics Co Ltd
0 catalysts
Phase 2
(mesalamine + hyaluronate sodium) DR
(mesalamine + hyaluronate sodium)
Ulcerative Colitis
Holy Stone Healthcare Co Ltd
0 catalysts
Phase 2
(methylprednisolone + zoledronic acid)
Osteoarthritis
Levolta Pharmaceuticals Inc
0 catalysts
Phase 2
(minoxidil + finasteride + latanoprost)
Androgenic Alopecia
Triple Hair Inc
0 catalysts
Phase 2
(nanatinostat + valganciclovir)
(nanatinostat + valganciclovir [INN])
Post-Transplant Lymphoproliferative Disorder
Viracta Therapeutics Inc
0 catalysts
Phase 2
(plerixafor + tacrolimus)
Wounds
MedRegen LLC
0 catalysts
Phase 2
(pramipexol + ondansetron)
(pramipexol + ondansetron [INN])
Treatment Resistant Depression
$ANROAlto Neuroscience, Inc.
0 catalysts
Phase 2
(prednisone + valproate sodium)
(prednisone [INN] + valproate sodium)
Diffuse Large B-Cell Lymphoma
Respiratorius AB
0 catalysts
Phase 2
(segesterone acetate + testosterone)
(segesterone acetate + testosterone [INN])
Male Contraception
Contraline Inc
0 catalysts
Phase 2
(senaparib + temozolomide)
(senaparib [INN] + temozolomide)
Small-Cell Lung Cancer
IMPACT Therapeutics Inc
0 catalysts
Phase 2
(sodium phenylbutyrate + taurursodiol)
Unspecified Genetic Disorders
$AMLXAmylyx Pharmaceuticals, Inc.
0 catalysts
Phase 2
177Lu-LNC-1011
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Yantai Lannacheng Biotechnology Co Ltd
0 catalysts
Phase 2
2-DG
Epilepsy
Hexokine Therapeutics Inc
0 catalysts
Phase 2
7MW-4911
Colorectal Cancer
Mabwell Shanghai Bioscience Co Ltd
0 catalysts
Phase 2
A-197
Keratoconjunctivitis Sicca (Dry Eye)
Aramis Biosciences Inc
0 catalysts
Phase 2
A-2B530
Metastatic Colorectal Cancer
A2 Biotherapeutics Inc
0 catalysts
Phase 2
A-2B543
Cervical Cancer
A2 Biotherapeutics Inc
0 catalysts
Phase 2
A2A-04
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Coiled Therapeutics Plc
0 catalysts
Phase 2
AAA-614
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$NVSNOVARTIS AG
0 catalysts
Phase 2
AAT-076
Pain
AskAt Inc
0 catalysts